カテゴリー： 世界, 医療/バイオ, LP Information

世界の非オピオイドパッチ市場予測 2023年-2029年

【英語タイトル】Global Non-Opioid Patch Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC11681）・商品コード：LP23DC11681
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の非オピオイドパッチ市場」は、過去の販売実績から2022年の世界の非オピオイドパッチの総販売量を検討し、2023年から2029年の予測される非オピオイドパッチの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の非オピオイドパッチの市場規模を掲載し、XXX百万米ドル規模の世界の非オピオイドパッチ市場の詳細な分析を提供します。本インサイトレポートは、世界の非オピオイドパッチ業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の非オピオイドパッチ市場における各社の独自のポジションをより深く理解するために、非オピオイドパッチ製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の非オピオイドパッチ市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。非オピオイドパッチの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。非オピオイドパッチの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。非オピオイドパッチのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

非オピオイドパッチの世界主要メーカーとしては、NEXGEL Advanced Hydrogel Solutions、 Viatris Inc.、 Johnson and Johnson、 Teva Pharmaceutical Industries Ltd、 Sorrento Therapeutics Inc.、 Hisamitsu Pharmaceutical Co.,Inc.、 Endo International plc.、 Purdue Pharma L.P.、 Amneal Pharmaceuticals LLC、 Grunenthalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の非オピオイドパッチ市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では非オピオイドパッチ市場をセグメンテーションし、種類別 (医療用医薬品、一般用医薬品)、用途別 (病院薬局、ドラッグストア、オンライン薬局)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：医療用医薬品、一般用医薬品

・用途別区分：病院薬局、ドラッグストア、オンライン薬局

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の非オピオイドパッチ市場の10年間の市場状況・展望は？
・世界および地域別に見た非オピオイドパッチ市場成長の要因は何か？
・非オピオイドパッチの市場機会はエンドマーケットの規模によってどのように変化するのか？
・非オピオイドパッチのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：非オピオイドパッチの年間販売量2018-2029、地域別現状・将来分析
・非オピオイドパッチの種類別セグメント：医療用医薬品、一般用医薬品
・非オピオイドパッチの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・非オピオイドパッチの用途別セグメント：病院薬局、ドラッグストア、オンライン薬局
・非オピオイドパッチの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の非オピオイドパッチ市場
・企業別のグローバル非オピオイドパッチ市場データ：2018-2023年の年間販売量、市場シェア
・企業別の非オピオイドパッチの年間売上：2018-2023年の売上、市場シェア
・企業別の非オピオイドパッチ販売価格
・主要企業の非オピオイドパッチ生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

非オピオイドパッチの地域別レビュー
・地域別の非オピオイドパッチ市場規模2018-2023：年間販売量、売上
・主要国別の非オピオイドパッチ市場規模2018-2023：年間販売量、売上
・南北アメリカの非オピオイドパッチ販売の成長
・アジア太平洋の非オピオイドパッチ販売の成長
・ヨーロッパの非オピオイドパッチ販売の成長
・中東・アフリカの非オピオイドパッチ販売の成長

南北アメリカ市場
・南北アメリカの国別の非オピオイドパッチ販売量、売上（2018-2023）
・南北アメリカの非オピオイドパッチの種類別販売量
・南北アメリカの非オピオイドパッチの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の非オピオイドパッチ販売量、売上（2018-2023）
・アジア太平洋の非オピオイドパッチの種類別販売量
・アジア太平洋の非オピオイドパッチの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の非オピオイドパッチ販売量、売上（2018-2023）
・ヨーロッパの非オピオイドパッチの種類別販売量
・ヨーロッパの非オピオイドパッチの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の非オピオイドパッチ販売量、売上（2018-2023）
・中東・アフリカの非オピオイドパッチの種類別販売量
・中東・アフリカの非オピオイドパッチの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・非オピオイドパッチの製造コスト構造分析
・非オピオイドパッチの製造プロセス分析
・非オピオイドパッチの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・非オピオイドパッチの主要なグローバル販売業者
・非オピオイドパッチの主要なグローバル顧客

地域別の非オピオイドパッチ市場予測レビュー
・地域別の非オピオイドパッチ市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・非オピオイドパッチの種類別市場規模予測
・非オピオイドパッチの用途別市場規模予測

主要企業分析
NEXGEL Advanced Hydrogel Solutions、 Viatris Inc.、 Johnson and Johnson、 Teva Pharmaceutical Industries Ltd、 Sorrento Therapeutics Inc.、 Hisamitsu Pharmaceutical Co.,Inc.、 Endo International plc.、 Purdue Pharma L.P.、 Amneal Pharmaceuticals LLC、 Grunenthal
・企業情報
・非オピオイドパッチ製品
・非オピオイドパッチ販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Non-Opioid Patch market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Non-Opioid Patch is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Non-Opioid Patch is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Non-Opioid Patch is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Non-Opioid Patch players cover NEXGEL Advanced Hydrogel Solutions, Viatris Inc., Johnson and Johnson, Teva Pharmaceutical Industries Ltd, Sorrento Therapeutics Inc., Hisamitsu Pharmaceutical Co.,Inc., Endo International plc., Purdue Pharma L.P. and Amneal Pharmaceuticals LLC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Non-Opioid Patch Industry Forecast” looks at past sales and reviews total world Non-Opioid Patch sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-Opioid Patch sales for 2023 through 2029. With Non-Opioid Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Opioid Patch industry.
This Insight Report provides a comprehensive analysis of the global Non-Opioid Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-Opioid Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-Opioid Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Opioid Patch and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Opioid Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Opioid Patch market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Prescription Medicines
OTC Medicines
Segmentation by application
Hospital Pharmacies
Drug Stores
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
NEXGEL Advanced Hydrogel Solutions
Viatris Inc.
Johnson and Johnson
Teva Pharmaceutical Industries Ltd
Sorrento Therapeutics Inc.
Hisamitsu Pharmaceutical Co.,Inc.
Endo International plc.
Purdue Pharma L.P.
Amneal Pharmaceuticals LLC
Grunenthal
Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-Opioid Patch market?
What factors are driving Non-Opioid Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-Opioid Patch market opportunities vary by end market size?
How does Non-Opioid Patch break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-Opioid Patch Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Non-Opioid Patch by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Non-Opioid Patch by Country/Region, 2018, 2022 & 2029
2.2 Non-Opioid Patch Segment by Type
2.2.1 Prescription Medicines
2.2.2 OTC Medicines
2.3 Non-Opioid Patch Sales by Type
2.3.1 Global Non-Opioid Patch Sales Market Share by Type (2018-2023)
2.3.2 Global Non-Opioid Patch Revenue and Market Share by Type (2018-2023)
2.3.3 Global Non-Opioid Patch Sale Price by Type (2018-2023)
2.4 Non-Opioid Patch Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Drug Stores
2.4.3 Online Pharmacies
2.5 Non-Opioid Patch Sales by Application
2.5.1 Global Non-Opioid Patch Sale Market Share by Application (2018-2023)
2.5.2 Global Non-Opioid Patch Revenue and Market Share by Application (2018-2023)
2.5.3 Global Non-Opioid Patch Sale Price by Application (2018-2023)
3 Global Non-Opioid Patch by Company
3.1 Global Non-Opioid Patch Breakdown Data by Company
3.1.1 Global Non-Opioid Patch Annual Sales by Company (2018-2023)
3.1.2 Global Non-Opioid Patch Sales Market Share by Company (2018-2023)
3.2 Global Non-Opioid Patch Annual Revenue by Company (2018-2023)
3.2.1 Global Non-Opioid Patch Revenue by Company (2018-2023)
3.2.2 Global Non-Opioid Patch Revenue Market Share by Company (2018-2023)
3.3 Global Non-Opioid Patch Sale Price by Company
3.4 Key Manufacturers Non-Opioid Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-Opioid Patch Product Location Distribution
3.4.2 Players Non-Opioid Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-Opioid Patch by Geographic Region
4.1 World Historic Non-Opioid Patch Market Size by Geographic Region (2018-2023)
4.1.1 Global Non-Opioid Patch Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Non-Opioid Patch Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Non-Opioid Patch Market Size by Country/Region (2018-2023)
4.2.1 Global Non-Opioid Patch Annual Sales by Country/Region (2018-2023)
4.2.2 Global Non-Opioid Patch Annual Revenue by Country/Region (2018-2023)
4.3 Americas Non-Opioid Patch Sales Growth
4.4 APAC Non-Opioid Patch Sales Growth
4.5 Europe Non-Opioid Patch Sales Growth
4.6 Middle East & Africa Non-Opioid Patch Sales Growth
5 Americas
5.1 Americas Non-Opioid Patch Sales by Country
5.1.1 Americas Non-Opioid Patch Sales by Country (2018-2023)
5.1.2 Americas Non-Opioid Patch Revenue by Country (2018-2023)
5.2 Americas Non-Opioid Patch Sales by Type
5.3 Americas Non-Opioid Patch Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Opioid Patch Sales by Region
6.1.1 APAC Non-Opioid Patch Sales by Region (2018-2023)
6.1.2 APAC Non-Opioid Patch Revenue by Region (2018-2023)
6.2 APAC Non-Opioid Patch Sales by Type
6.3 APAC Non-Opioid Patch Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-Opioid Patch by Country
7.1.1 Europe Non-Opioid Patch Sales by Country (2018-2023)
7.1.2 Europe Non-Opioid Patch Revenue by Country (2018-2023)
7.2 Europe Non-Opioid Patch Sales by Type
7.3 Europe Non-Opioid Patch Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-Opioid Patch by Country
8.1.1 Middle East & Africa Non-Opioid Patch Sales by Country (2018-2023)
8.1.2 Middle East & Africa Non-Opioid Patch Revenue by Country (2018-2023)
8.2 Middle East & Africa Non-Opioid Patch Sales by Type
8.3 Middle East & Africa Non-Opioid Patch Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-Opioid Patch
10.3 Manufacturing Process Analysis of Non-Opioid Patch
10.4 Industry Chain Structure of Non-Opioid Patch
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-Opioid Patch Distributors
11.3 Non-Opioid Patch Customer
12 World Forecast Review for Non-Opioid Patch by Geographic Region
12.1 Global Non-Opioid Patch Market Size Forecast by Region
12.1.1 Global Non-Opioid Patch Forecast by Region (2024-2029)
12.1.2 Global Non-Opioid Patch Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-Opioid Patch Forecast by Type
12.7 Global Non-Opioid Patch Forecast by Application
13 Key Players Analysis
13.1 NEXGEL Advanced Hydrogel Solutions
13.1.1 NEXGEL Advanced Hydrogel Solutions Company Information
13.1.2 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolios and Specifications
13.1.3 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 NEXGEL Advanced Hydrogel Solutions Main Business Overview
13.1.5 NEXGEL Advanced Hydrogel Solutions Latest Developments
13.2 Viatris Inc.
13.2.1 Viatris Inc. Company Information
13.2.2 Viatris Inc. Non-Opioid Patch Product Portfolios and Specifications
13.2.3 Viatris Inc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Viatris Inc. Main Business Overview
13.2.5 Viatris Inc. Latest Developments
13.3 Johnson and Johnson
13.3.1 Johnson and Johnson Company Information
13.3.2 Johnson and Johnson Non-Opioid Patch Product Portfolios and Specifications
13.3.3 Johnson and Johnson Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Johnson and Johnson Main Business Overview
13.3.5 Johnson and Johnson Latest Developments
13.4 Teva Pharmaceutical Industries Ltd
13.4.1 Teva Pharmaceutical Industries Ltd Company Information
13.4.2 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolios and Specifications
13.4.3 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.4.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.5 Sorrento Therapeutics Inc.
13.5.1 Sorrento Therapeutics Inc. Company Information
13.5.2 Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolios and Specifications
13.5.3 Sorrento Therapeutics Inc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sorrento Therapeutics Inc. Main Business Overview
13.5.5 Sorrento Therapeutics Inc. Latest Developments
13.6 Hisamitsu Pharmaceutical Co.,Inc.
13.6.1 Hisamitsu Pharmaceutical Co.,Inc. Company Information
13.6.2 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolios and Specifications
13.6.3 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hisamitsu Pharmaceutical Co.,Inc. Main Business Overview
13.6.5 Hisamitsu Pharmaceutical Co.,Inc. Latest Developments
13.7 Endo International plc.
13.7.1 Endo International plc. Company Information
13.7.2 Endo International plc. Non-Opioid Patch Product Portfolios and Specifications
13.7.3 Endo International plc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Endo International plc. Main Business Overview
13.7.5 Endo International plc. Latest Developments
13.8 Purdue Pharma L.P.
13.8.1 Purdue Pharma L.P. Company Information
13.8.2 Purdue Pharma L.P. Non-Opioid Patch Product Portfolios and Specifications
13.8.3 Purdue Pharma L.P. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Purdue Pharma L.P. Main Business Overview
13.8.5 Purdue Pharma L.P. Latest Developments
13.9 Amneal Pharmaceuticals LLC
13.9.1 Amneal Pharmaceuticals LLC Company Information
13.9.2 Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolios and Specifications
13.9.3 Amneal Pharmaceuticals LLC Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Amneal Pharmaceuticals LLC Main Business Overview
13.9.5 Amneal Pharmaceuticals LLC Latest Developments
13.10 Grunenthal
13.10.1 Grunenthal Company Information
13.10.2 Grunenthal Non-Opioid Patch Product Portfolios and Specifications
13.10.3 Grunenthal Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Grunenthal Main Business Overview
13.10.5 Grunenthal Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Non-Opioid Patch Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Non-Opioid Patch Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Prescription Medicines
Table 4. Major Players of OTC Medicines
Table 5. Global Non-Opioid Patch Sales by Type (2018-2023) & (K Units)
Table 6. Global Non-Opioid Patch Sales Market Share by Type (2018-2023)
Table 7. Global Non-Opioid Patch Revenue by Type (2018-2023) & ($ million)
Table 8. Global Non-Opioid Patch Revenue Market Share by Type (2018-2023)
Table 9. Global Non-Opioid Patch Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Non-Opioid Patch Sales by Application (2018-2023) & (K Units)
Table 11. Global Non-Opioid Patch Sales Market Share by Application (2018-2023)
Table 12. Global Non-Opioid Patch Revenue by Application (2018-2023)
Table 13. Global Non-Opioid Patch Revenue Market Share by Application (2018-2023)
Table 14. Global Non-Opioid Patch Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Non-Opioid Patch Sales by Company (2018-2023) & (K Units)
Table 16. Global Non-Opioid Patch Sales Market Share by Company (2018-2023)
Table 17. Global Non-Opioid Patch Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Non-Opioid Patch Revenue Market Share by Company (2018-2023)
Table 19. Global Non-Opioid Patch Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Non-Opioid Patch Producing Area Distribution and Sales Area
Table 21. Players Non-Opioid Patch Products Offered
Table 22. Non-Opioid Patch Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Non-Opioid Patch Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Non-Opioid Patch Sales Market Share Geographic Region (2018-2023)
Table 27. Global Non-Opioid Patch Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Non-Opioid Patch Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Non-Opioid Patch Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Non-Opioid Patch Sales Market Share by Country/Region (2018-2023)
Table 31. Global Non-Opioid Patch Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Non-Opioid Patch Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Non-Opioid Patch Sales by Country (2018-2023) & (K Units)
Table 34. Americas Non-Opioid Patch Sales Market Share by Country (2018-2023)
Table 35. Americas Non-Opioid Patch Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Non-Opioid Patch Revenue Market Share by Country (2018-2023)
Table 37. Americas Non-Opioid Patch Sales by Type (2018-2023) & (K Units)
Table 38. Americas Non-Opioid Patch Sales by Application (2018-2023) & (K Units)
Table 39. APAC Non-Opioid Patch Sales by Region (2018-2023) & (K Units)
Table 40. APAC Non-Opioid Patch Sales Market Share by Region (2018-2023)
Table 41. APAC Non-Opioid Patch Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Non-Opioid Patch Revenue Market Share by Region (2018-2023)
Table 43. APAC Non-Opioid Patch Sales by Type (2018-2023) & (K Units)
Table 44. APAC Non-Opioid Patch Sales by Application (2018-2023) & (K Units)
Table 45. Europe Non-Opioid Patch Sales by Country (2018-2023) & (K Units)
Table 46. Europe Non-Opioid Patch Sales Market Share by Country (2018-2023)
Table 47. Europe Non-Opioid Patch Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Non-Opioid Patch Revenue Market Share by Country (2018-2023)
Table 49. Europe Non-Opioid Patch Sales by Type (2018-2023) & (K Units)
Table 50. Europe Non-Opioid Patch Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Non-Opioid Patch Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Non-Opioid Patch Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Non-Opioid Patch Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Non-Opioid Patch Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Non-Opioid Patch Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Non-Opioid Patch Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Non-Opioid Patch
Table 58. Key Market Challenges & Risks of Non-Opioid Patch
Table 59. Key Industry Trends of Non-Opioid Patch
Table 60. Non-Opioid Patch Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Non-Opioid Patch Distributors List
Table 63. Non-Opioid Patch Customer List
Table 64. Global Non-Opioid Patch Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Non-Opioid Patch Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Non-Opioid Patch Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Non-Opioid Patch Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Non-Opioid Patch Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Non-Opioid Patch Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Non-Opioid Patch Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Non-Opioid Patch Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Non-Opioid Patch Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Non-Opioid Patch Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Non-Opioid Patch Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Non-Opioid Patch Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Non-Opioid Patch Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Non-Opioid Patch Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. NEXGEL Advanced Hydrogel Solutions Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 79. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolios and Specifications
Table 80. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. NEXGEL Advanced Hydrogel Solutions Main Business
Table 82. NEXGEL Advanced Hydrogel Solutions Latest Developments
Table 83. Viatris Inc. Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 84. Viatris Inc. Non-Opioid Patch Product Portfolios and Specifications
Table 85. Viatris Inc. Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Viatris Inc. Main Business
Table 87. Viatris Inc. Latest Developments
Table 88. Johnson and Johnson Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 89. Johnson and Johnson Non-Opioid Patch Product Portfolios and Specifications
Table 90. Johnson and Johnson Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Johnson and Johnson Main Business
Table 92. Johnson and Johnson Latest Developments
Table 93. Teva Pharmaceutical Industries Ltd Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 94. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolios and Specifications
Table 95. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Teva Pharmaceutical Industries Ltd Main Business
Table 97. Teva Pharmaceutical Industries Ltd Latest Developments
Table 98. Sorrento Therapeutics Inc. Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 99. Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolios and Specifications
Table 100. Sorrento Therapeutics Inc. Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Sorrento Therapeutics Inc. Main Business
Table 102. Sorrento Therapeutics Inc. Latest Developments
Table 103. Hisamitsu Pharmaceutical Co.,Inc. Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 104. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolios and Specifications
Table 105. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Hisamitsu Pharmaceutical Co.,Inc. Main Business
Table 107. Hisamitsu Pharmaceutical Co.,Inc. Latest Developments
Table 108. Endo International plc. Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 109. Endo International plc. Non-Opioid Patch Product Portfolios and Specifications
Table 110. Endo International plc. Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Endo International plc. Main Business
Table 112. Endo International plc. Latest Developments
Table 113. Purdue Pharma L.P. Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 114. Purdue Pharma L.P. Non-Opioid Patch Product Portfolios and Specifications
Table 115. Purdue Pharma L.P. Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Purdue Pharma L.P. Main Business
Table 117. Purdue Pharma L.P. Latest Developments
Table 118. Amneal Pharmaceuticals LLC Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 119. Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolios and Specifications
Table 120. Amneal Pharmaceuticals LLC Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Amneal Pharmaceuticals LLC Main Business
Table 122. Amneal Pharmaceuticals LLC Latest Developments
Table 123. Grunenthal Basic Information, Non-Opioid Patch Manufacturing Base, Sales Area and Its Competitors
Table 124. Grunenthal Non-Opioid Patch Product Portfolios and Specifications
Table 125. Grunenthal Non-Opioid Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Grunenthal Main Business
Table 127. Grunenthal Latest Developments
List of Figures
Figure 1. Picture of Non-Opioid Patch
Figure 2. Non-Opioid Patch Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-Opioid Patch Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Non-Opioid Patch Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Non-Opioid Patch Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Prescription Medicines
Figure 10. Product Picture of OTC Medicines
Figure 11. Global Non-Opioid Patch Sales Market Share by Type in 2022
Figure 12. Global Non-Opioid Patch Revenue Market Share by Type (2018-2023)
Figure 13. Non-Opioid Patch Consumed in Hospital Pharmacies
Figure 14. Global Non-Opioid Patch Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 15. Non-Opioid Patch Consumed in Drug Stores
Figure 16. Global Non-Opioid Patch Market: Drug Stores (2018-2023) & (K Units)
Figure 17. Non-Opioid Patch Consumed in Online Pharmacies
Figure 18. Global Non-Opioid Patch Market: Online Pharmacies (2018-2023) & (K Units)
Figure 19. Global Non-Opioid Patch Sales Market Share by Application (2022)
Figure 20. Global Non-Opioid Patch Revenue Market Share by Application in 2022
Figure 21. Non-Opioid Patch Sales Market by Company in 2022 (K Units)
Figure 22. Global Non-Opioid Patch Sales Market Share by Company in 2022
Figure 23. Non-Opioid Patch Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Non-Opioid Patch Revenue Market Share by Company in 2022
Figure 25. Global Non-Opioid Patch Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Non-Opioid Patch Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Non-Opioid Patch Sales 2018-2023 (K Units)
Figure 28. Americas Non-Opioid Patch Revenue 2018-2023 ($ Millions)
Figure 29. APAC Non-Opioid Patch Sales 2018-2023 (K Units)
Figure 30. APAC Non-Opioid Patch Revenue 2018-2023 ($ Millions)
Figure 31. Europe Non-Opioid Patch Sales 2018-2023 (K Units)
Figure 32. Europe Non-Opioid Patch Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Non-Opioid Patch Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Non-Opioid Patch Revenue 2018-2023 ($ Millions)
Figure 35. Americas Non-Opioid Patch Sales Market Share by Country in 2022
Figure 36. Americas Non-Opioid Patch Revenue Market Share by Country in 2022
Figure 37. Americas Non-Opioid Patch Sales Market Share by Type (2018-2023)
Figure 38. Americas Non-Opioid Patch Sales Market Share by Application (2018-2023)
Figure 39. United States Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Non-Opioid Patch Sales Market Share by Region in 2022
Figure 44. APAC Non-Opioid Patch Revenue Market Share by Regions in 2022
Figure 45. APAC Non-Opioid Patch Sales Market Share by Type (2018-2023)
Figure 46. APAC Non-Opioid Patch Sales Market Share by Application (2018-2023)
Figure 47. China Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Non-Opioid Patch Sales Market Share by Country in 2022
Figure 55. Europe Non-Opioid Patch Revenue Market Share by Country in 2022
Figure 56. Europe Non-Opioid Patch Sales Market Share by Type (2018-2023)
Figure 57. Europe Non-Opioid Patch Sales Market Share by Application (2018-2023)
Figure 58. Germany Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Non-Opioid Patch Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Non-Opioid Patch Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Non-Opioid Patch Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Non-Opioid Patch Sales Market Share by Application (2018-2023)
Figure 67. Egypt Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Non-Opioid Patch Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Non-Opioid Patch in 2022
Figure 73. Manufacturing Process Analysis of Non-Opioid Patch
Figure 74. Industry Chain Structure of Non-Opioid Patch
Figure 75. Channels of Distribution
Figure 76. Global Non-Opioid Patch Sales Market Forecast by Region (2024-2029)
Figure 77. Global Non-Opioid Patch Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Non-Opioid Patch Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Non-Opioid Patch Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Non-Opioid Patch Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Non-Opioid Patch Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の非オピオイドパッチ市場予測 2023年-2029年] (コード：LP23DC11681)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の非オピオイドパッチ市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の非オピオイド鎮痛薬市場予測 2023年-2029年
  • 世界のニコチンスキンパッチ市場予測 2023年-2029年
  • 世界の医療用ニコチン経皮パッチ市場予測 2023年-2029年
  • 世界の部分吸収性ヘルニア修復パッチ市場予測 2023年-2029年
  • 世界のウシ心膜パッチ市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆